logo
Plus   Neg
Share
Email

Brazil's XP Prices IPO At $27/shr, Above Proposed Range

XP Inc., a provider of brokerage, investment-advisory and asset-management services in Brazil, said that it has priced its initial public offering of 72.51 million of its Class A common shares at a price of $27.00 per share.

According to recent regulatory filings, the company and selling stockholders planned to offer 72.51 million shares in the range of US$22.00 and US$25.00 per share.

XP Inc said it is issuing and selling 42.55 million Class A common shares and certain selling shareholders are selling 29.96 million Class A common shares. The shares are expected to begin trading on the Nasdaq Global Select Market on December 11, 2019, under the symbol "XP" and the offering is expected to close on December 13, 2019.

In connection with the offering, the selling shareholders have granted the underwriters a 30-day option to purchase up to an additional 10.88 million Class A common shares at the initial public offering price less the underwriting discount.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration has granted accelerated approval to Tazverik for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. Epithelioid sarcoma is a rare sub-type of soft... STIHL recalls about 16,400 STIHL RE 90 pressure washers due to injury hazard. According to the company, the recalled pressure washer nozzle can disconnect from the spray wand when under pressure during use, posing an injury hazard. STIHL said it received seven reports of the nozzle detaching from... CVS Health Corp. launched 13 new HealthHUB locations in CVS Pharmacy stores across Philadelphia and South New Jersey. The healthcare company said it developed the HealthHUB store format to help people manage chronic conditions more conveniently and affordably. The store also features health and wellness products, clinical services and expertise.
RELATED NEWS
Follow RTT
>